These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Subconjunctival triamcinolone acetonide in the management of ocular inflammatory disease. Athanasiadis Y; Tsatsos M; Sharma A; Hossain P J Ocul Pharmacol Ther; 2013; 29(6):516-22. PubMed ID: 23485045 [TBL] [Abstract][Full Text] [Related]
23. Malignant glaucoma as a complication of intravitreal triamcinolone acetonide. Heatley CJ; Lim KS; Siriwardena D; Barton K Acta Ophthalmol Scand; 2006 Oct; 84(5):712-3. PubMed ID: 16965510 [No Abstract] [Full Text] [Related]
24. Periocular triamcinolone acetonide injections for control of intraocular inflammation associated with uveitis. Salek SS; Leder HA; Butler NJ; Gan TJ; Dunn JP; Thorne JE Ocul Immunol Inflamm; 2013 Aug; 21(4):257-63. PubMed ID: 23617776 [TBL] [Abstract][Full Text] [Related]
25. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide. Agrawal S; Agrawal J; Agrawal TP Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813 [TBL] [Abstract][Full Text] [Related]
26. The use of intraocular corticosteroids. Kiernan DF; Mieler WF Expert Opin Pharmacother; 2009 Oct; 10(15):2511-25. PubMed ID: 19761356 [TBL] [Abstract][Full Text] [Related]
33. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972 [TBL] [Abstract][Full Text] [Related]
34. Triamcinolone intravitreal injection and intraocular pressure in macular edema associated with retinal vein occlusion. Wei Y; Wang HZ; Chen FH; Wang RS; Yang XG Eye Sci; 2012 Dec; 27(4):182-7. PubMed ID: 23225839 [TBL] [Abstract][Full Text] [Related]
35. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Jonas JB Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641 [TBL] [Abstract][Full Text] [Related]
36. A Common Procedure With an Uncommon Pathology: Triamcinolone Acetonide Eyelid Injection. Wolkow N; Jakobiec FA; Hatton MP Ophthalmic Plast Reconstr Surg; 2018; 34(3):e72-e73. PubMed ID: 29346171 [TBL] [Abstract][Full Text] [Related]
37. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant. Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937 [TBL] [Abstract][Full Text] [Related]
38. Ocular complications after a sub-tenon injection of triamcinolone acetonide for uveitis. Kuo HK; Lai IC; Fang PC; Teng MC Chang Gung Med J; 2005 Feb; 28(2):85-9. PubMed ID: 15880983 [TBL] [Abstract][Full Text] [Related]
39. Current management of uveitis-associated ocular hypertension and glaucoma. Kesav N; Palestine AG; Kahook MY; Pantcheva MB Surv Ophthalmol; 2020; 65(4):397-407. PubMed ID: 31816329 [TBL] [Abstract][Full Text] [Related]
40. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]